Altmetrics data for Nature Communications articles, Oct '13 - Oct '14 - http://www.mendeley.com/c...
Euan Adie et al. Published using Mendeley: The research tool for desktop & web - Mr. Gunn
Male spine motion during coitus: implications for the low back pain patient. - http://www.mendeley.com/c...
Spine (2014). Volume: 39, Issue: 20. Pages: 1633-9. Natalie Sidorkewicz, Stuart M McGill et al. STUDY DESIGN: Repeated measures design. OBJECTIVE: To describe male spine movement and posture characteristics during coitus and compare these characteristics across 5 common coital positions. SUMMARY OF BACKGROUND DATA: Exacerbation of pain during coitus due to coital movements and positions is a prevalent issue reported by low back pain patients. A biomechanical analysis of spine movements and postures during coitus has never been conducted. METHODS: Ten healthy males and females engaged in coitus in the following preselected positions and variations: QUADRUPED, MISSIONARY, and SIDELYING. An optoelectronic motion capture system was used to measure 3-dimensional lumbar spine angles that were normalized to upright standing. To determine whether each coital position had distinct spine kinematic profiles, separate univariate general linear models, followed by Tukey's honestly significant... - Mr. Gunn
MrGunn on Science AMA Series: I'm Rebecca Lawrence, Managing Director of F1000Research, an Open Science publishing platform designed to turn traditional publishing models on their head. The journal is dead – discuss, and AMA - http://www.reddit.com/r...
"But Easternblot's point is that print media isn't inherently more stable or secure. How much research was destroyed in the riots in the Arab Spring and subsequent fighting in Iraq and elsewhere? The CLOCKSS system that EB refers too was developed over many years by a consortium of librarians and publishers, exactly the sort of people to whom we have always entrusted the job of preservation of research. These people know what they're doing." - Mr. Gunn
MrGunn on Science AMA Series: I'm Rebecca Lawrence, Managing Director of F1000Research, an Open Science publishing platform designed to turn traditional publishing models on their head. The journal is dead – discuss, and AMA - http://www.reddit.com/r...
"There's http://experiment.com and others like that propose exactly this, but some people are already using [Indiegogo](https://www.indiegogo.com/project...), [Kickstarter](https://www.kickstarter.com/project...), and [RocketHub](http://www.rockethub.com/project...) for this." - Mr. Gunn
MrGunn on Science AMA Series: I'm Rebecca Lawrence, Managing Director of F1000Research, an Open Science publishing platform designed to turn traditional publishing models on their head. The journal is dead – discuss, and AMA - http://www.reddit.com/r...
"article-level metrics or altmetrics: ImpactStory, http://alm.plos.org/ altmetric.com preprint: [SSRN](http://www.ssrn.com/) megajournals: [PLOS ONE](http;//plosone.org) independent peer review: [Pubmed Commons](http://www.ncbi.nlm.nih.gov/pubmedc...) and also PubPeer, Publons, Peerage of Science (there's dozens)" - Mr. Gunn
MrGunn on Science AMA Series: I'm Rebecca Lawrence, Managing Director of F1000Research, an Open Science publishing platform designed to turn traditional publishing models on their head. The journal is dead – discuss, and AMA - http://www.reddit.com/r...
"All very good points, but when you take these concerns to funders and publishers, as I have, they say that what they do is driven by what researchers want. You see the same dynamic in the popular press. People complain about clickbait, but respected newspapers are getting more and more into clickbait from watching the success of things like Buzzfeed and Upworthy. So we have to bring about change from within. As long as the belief that you have to publish in C/N/S to get grants exists, people will still compete to publish in C/N/S. You, I, and everyone else who reviews papers or grants has to stand up against this and bring change from within." - Mr. Gunn
MrGunn on Science AMA Series: I'm Rebecca Lawrence, Managing Director of F1000Research, an Open Science publishing platform designed to turn traditional publishing models on their head. The journal is dead – discuss, and AMA - http://www.reddit.com/r...
"I can't speak for all of Elsevier, but the Mendeley team quite likes F1000Research and I know many within Elsevier who also appreciate the approach. Elsevier has yet to launch their own "megajournal"-style journal like PLOS ONE, but they have experimented with open peer review and you never know what the future may hold... ;-)" - Mr. Gunn
MrGunn on Science AMA Series: I'm Rebecca Lawrence, Managing Director of F1000Research, an Open Science publishing platform designed to turn traditional publishing models on their head. The journal is dead – discuss, and AMA - http://www.reddit.com/r...
"With F1000Research and others such as PLOS ONE, the money comes from the authors & this also allows the journal to retain editorial staff." - Mr. Gunn
MrGunn on Science AMA Series: I'm Rebecca Lawrence, Managing Director of F1000Research, an Open Science publishing platform designed to turn traditional publishing models on their head. The journal is dead – discuss, and AMA - http://www.reddit.com/r...
"See http://osf.io/ for the leading example of a group trying what you're talking about." - Mr. Gunn
MrGunn on Science AMA Series: I'm Rebecca Lawrence, Managing Director of F1000Research, an Open Science publishing platform designed to turn traditional publishing models on their head. The journal is dead – discuss, and AMA - http://www.reddit.com/r...
"As Rebecca mentioned above, many have tried to build open peer review platforms and one thing we know is that putting articles up and hoping they'll be found by the right person just doesn't work. There are too many articles & too people who have something worthwhile to say about any one given article. Additionally, the people who have the most to say have the least time and inclination to do so, particularly on a site which is new to them. That's why I think Pubmed Commons has the best chance among non-journal platforms." - Mr. Gunn
MrGunn on Science AMA Series: I'm Rebecca Lawrence, Managing Director of F1000Research, an Open Science publishing platform designed to turn traditional publishing models on their head. The journal is dead – discuss, and AMA - http://www.reddit.com/r...
"In fact, no one does review for the journals with problems, but that doesn't stop these outfits from listing many prestigious academics as reviewers without their knowledge or permission." - Mr. Gunn
MrGunn on Science AMA Series: I'm Rebecca Lawrence, Managing Director of F1000Research, an Open Science publishing platform designed to turn traditional publishing models on their head. The journal is dead – discuss, and AMA - http://www.reddit.com/r...
"This is true, and many people have begun to work on bringing the discovery mechanisms common on the internet to the scholarly realm. See altmetrics.org, impactStory, altmetric.com, Plum Analytics, etc." - Mr. Gunn
MrGunn on Science AMA Series: I'm Rebecca Lawrence, Managing Director of F1000Research, an Open Science publishing platform designed to turn traditional publishing models on their head. The journal is dead – discuss, and AMA - http://www.reddit.com/r...
"The identities of reviewers are anonymous, but the editorial boards of journals are advertised on the journal sites." - Mr. Gunn
MrGunn on Science AMA Series: I'm Rebecca Lawrence, Managing Director of F1000Research, an Open Science publishing platform designed to turn traditional publishing models on their head. The journal is dead – discuss, and AMA - http://www.reddit.com/r...
"The best examples in this space (PLOS ONE, eLife, PeerJ, Scientific Reports, and F1000Research) keep a strict firewall between editorial and financial. No one involved in the acceptance decision knows if the manuscript has paid full fare or qualified under a fee waiver scheme. They also use academic editors and reviewers, who are external to the journal, to give reviews and make recommendations, which insulates them from some bias." - Mr. Gunn
Imperative for Open Altmetrics - http://www.mendeley.com/c...
Stacy Konkiel, Heather Piwowar, Jason Priem et al. Published using Mendeley: The reference software for researchers - Mr. Gunn
Tweets as impact indicators: Examining the implications of automated bot accounts on Twitter - http://www.mendeley.com/c...
Stefanie Haustein, Timothy D. Bowman, Kim Holmberg, Andrew Tsou, Cassidy R. Sugimoto, Vincent Larivière et al. Published using Mendeley: The bibliography manager for researchers - Mr. Gunn
Alluvial Diagram Showing the Publishers of the Top 100 Ebola Papers According to Altmetric as of Wed Aug 06 2014 16/44/28 GMT+0000 (UTC) by License and Access Type - http://www.mendeley.com/c...
Ernesto Priego et al. Published using Mendeley: The research tool for desktop & web - Mr. Gunn
Rise of the Rest: The Growing Impact of Non-Elite Journals - http://www.mendeley.com/c...
Pages: 1-11. Anurag Acharya, Alex Verstak, Helder Suzuki, Sean Henderson, Mikhail Iakhiaev, Cliff Chiung Yu Lin, Namit Shetty et al. Published using Mendeley: The reference manager for researchers - Mr. Gunn
At Palo Alto High School tomorrow: "The Impact of Mass Surveillance on the Digital Economy" http://www.eventbrite.com/e... w/ @EricSchmidt @RonWyden
Visualization of Co-Readership Patterns from an Online Reference Management System - http://www.mendeley.com/c...
Peter Kraker, Christian Schlögl, Kris Jack, Stefanie Lindstaedt et al. Published using Mendeley: Academic software for researchers - Mr. Gunn
Do Altmetrics Follow the Crowd or Does the Crowd Follow Altmetrics? - http://www.mendeley.com/c...
IEEE/ACM Joint Conference on Digital Libraries (2014). Hamed Alhoori, Richard Furuta et al. Published using Mendeley: The library management tool for researchers - Mr. Gunn
AAAS 2014: How the Web Changes Collaboration - http://www.slideshare.net/william...
Charleston 2013: The Social Side of Research - http://www.slideshare.net/william...
Charleston 2012: Altmetrics: Analyzing the Value in Scholarly Content - http://www.slideshare.net/william...
RT @ErrataRob: There are more Apple and Android devices than IPv4 addresses. I guess IPv6 came just in time, or they couldn't connect to the Internet.
Lots of apple whatevers at #OSCodefest for sure, but I consistently see lots of ThinkPads, too.
RT @mathewi: New from me: "Twitter CFO says a Facebook-style filtered feed is coming, whether you like it or not" http://gigaom.com/2014...
RT @mia_out: Bring on the scholarly commons! 'The PeerLibrary Community' http://vimeo.com/93085636 Site https://t.co/RdWElxGOR9 HT @Tracy_Jentzsch
Reinventing Discovery: The New Era of Networked Science [Hardcover] - http://www.mendeley.com/c...
Princeton University Press (2011). Pages: 280. Michael Nielsen et al. Published using Mendeley: The reference manager for researchers - Mr. Gunn
Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review. - http://www.mendeley.com/c...
Biochemical pharmacology (2014). Limei Wang, Birgit Waltenberger, Eva-Maria Pferschy-Wenzig, Martina Blunder, Xin Liu, Clemens Malainer, Tina Blazevic, Stefan Schwaiger, Judith M Rollinger, Elke H Heiss, Daniela Schuster, Brigitte Kopp, Rudolf Bauer, Hermann Stuppner, Verena M Dirsch, Atanas G Atanasov et al. Agonists of the nuclear receptor PPARγ are therapeutically used to combat hyperglycaemia associated with the metabolic syndrome and type 2 diabetes. In spite of being effective in normalization of blood glucose levels, the currently used PPARγ agonists from the thiazolidinedione type have serious side effects, making the discovery of novel ligands highly relevant. Natural products have proven historically to be a promising pool of structures for drug discovery, and a significant research effort has recently been undertaken to explore the PPARγ-activating potential of a wide range of natural products originating from traditionally used medicinal plants or dietary sources. The... - Mr. Gunn
Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review. - http://www.mendeley.com/c...
Biochemical pharmacology (2014). Limei Wang, Birgit Waltenberger, Eva-Maria Pferschy-Wenzig, Martina Blunder, Xin Liu, Clemens Malainer, Tina Blazevic, Stefan Schwaiger, Judith M Rollinger, Elke H Heiss, Daniela Schuster, Brigitte Kopp, Rudolf Bauer, Hermann Stuppner, Verena M Dirsch, Atanas G Atanasov et al. Agonists of the nuclear receptor PPARγ are therapeutically used to combat hyperglycaemia associated with the metabolic syndrome and type 2 diabetes. In spite of being effective in normalization of blood glucose levels, the currently used PPARγ agonists from the thiazolidinedione type have serious side effects, making the discovery of novel ligands highly relevant. Natural products have proven historically to be a promising pool of structures for drug discovery, and a significant research effort has recently been undertaken to explore the PPARγ-activating potential of a wide range of natural products originating from traditionally used medicinal plants or dietary sources. The... - Mr. Gunn